Sangamo BioSciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 17 Posts
1 2
Biotechnology Stocks Preparing A New Bullish Trend
Article By: Taki Tsaklanos Sunday, July 8, 2018 11:26 AM EST
Biotechnology stocks look bullish, and even more bullish than ever in the last three years.
In this article: IBB, ILMN, REGN, BIIB, CELG, XBI, ARRY, FOLD, SGMO, XLRN
Read
Recession Is Coming! Not.
Article By: Kevin Cook Sunday, February 25, 2018 8:20 AM EST
We can bank on stocks continuing to "bubble up" over the next year and we need only keep a vigilant eye on the inflation/rates picture and economic data for early signs of trouble (of which I see few now).
In this article: LRCX, EW, SGMO, NVDA, BABA, BLUE
Read
Sangamo Therapeutics - Chart Of The Day
Article By: Jim Van Meerten Thursday, January 25, 2018 3:56 PM EST
Since the Trend Spotter signaled a buy in 11/17 the stock gained 42.22%.
In this article: SGMO
Read
5 Of The Best-Performing Biotech Stocks Of 2017
Article By: Arpita Dutt Sunday, December 31, 2017 3:46 PM EST
2017 turned out to be a pretty good year for the biotech sector. The sector had been struggling due to the drug pricing controversy, mixed results, slower-than-expected new product launches, increasing competition and pipeline setbacks.
In this article: XOMA, DVAX, SGMO, ALNY, BLUE, PFE, GILD
Read
4 Biotech Stocks Ready To Crush The Market In 2018
Article By: Zacks Investment Research Wednesday, December 27, 2017 7:51 PM EST
The year 2017 has been quite impressive one for the biotech sector as evident from the 19.4% gain registered so far by the Nasdaq Biotechnology Index. This is surely welcome news for investors since the industry suffered a decline of 19.2% last year.
In this article: SBMFF, ACAD, SGMO, ANAB Also: CELG, GILD
Read
These 5 Stocks Have Popped More Than 100% Since Trump's Win
Article By: Swarup Gupta Wednesday, December 13, 2017 5:07 PM EST
Following a particularly strong jobs report last week, President Trump once again took to Twitter to tout the economy’s stellar performance during his tenure.
In this article: SGMO, TREE, RH, RXDX, SEDG
Read
Best Sector ETF Of Q3 And Its Top-Performing Stocks
Article By: Sweta Killa Monday, October 2, 2017 3:08 PM EST
The biotech sector led the U.S. stock market higher last quarter with Virtus LifeSci Biotech Clinical Trials ETF topping the list of the best-performing ETFs, logging impressive returns of about 21.4%.
In this article: SGMO, DVAX, INSM, KITE, MYOK, BBC
Read
4 Biotech Stocks That Show Promise On Sustainable Growth
Article By: Zacks Investment Research Friday, September 15, 2017 7:20 AM EST
Within the Medical sector, biotech stocks have performed well in the first half of the year, despite challenges like rising competition, pipeline setbacks, slowdown in growth of mature products and generic competition for certain key drugs.
In this article: SGMO, CORT, HSKA, HLUYY Also: LLY, ALXN, GILD, KITE
Read
5 Top-Ranked Biotech Stocks To Buy Right Now
Article By: Arpita Dutt Monday, September 11, 2017 1:09 PM EST
Picking biotech stocks can be a bit tricky given the “high risk - high returns” nature of the industry. Moreover, the estimate revision trend for the sector is not very encouraging.
In this article: REGN, ALXN, LGND, SGMO, FATE Also: KITE, GILD
Read
3 Biotech Stocks That More Than Doubled Year To Date
Article By: Arpita Dutt Monday, June 19, 2017 2:24 PM EST
Year-to-date (YTD), the Nasdaq Biotechnology Index is up 10.4% providing a glimmer of hope to biotech investors who saw the Index sliding 19.1% in 2016.
In this article: PBYI, SGMO, CYAD Also: PFE
Read
3 Hot Biotech Stocks To Buy In June
Article By: Arpita Dutt Thursday, June 1, 2017 11:29 AM EST
While drug pricing will remain a headline risk until some plan is announced by the administration, here are a few biotech stocks that have performed well YTD and look well-positioned.
In this article: REGN, SGMO, PBYI
Read
E Sangamo Biosciences Continues Its Climb After Pfizer Partnership
Article By: Terry Chrisomalis Friday, May 12, 2017 1:26 PM EST
After yesterday's 60% gain, Sangamo climbed another 15% today on the potential of its Pfizer deal.
In this article: SGMO, PFE
Read
E How CRISPR Technology May Save Your Life
Article By: John Thomas Tuesday, August 9, 2016 12:00 PM EST
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). Memorize this term, and put it on a post it note on your computer. It may save your life some day, if not add decades to it. And it could also make you a multimillionaire.
In this article: TMO, SGMO, OVAS, CLLS
Read
Sangamo BioSciences Provides Well Defined Opportunity
Article By: David Zarling Monday, February 23, 2015 8:22 PM EST
Since releasing earnings, SGMO has moved to a well-defined inflection point. The price pattern over the past year has created a classic Inverse Head and Shoulders pattern. This provides upward reward targets. We like this opportunity.
In this article: SGMO
Read
E Sangamo's Technology Can Possibly Advance New Treatments For Patients With HIV
Article By: Terry Chrisomalis Wednesday, May 28, 2014 10:14 AM EST
Sangamo has the ability to improve HIV patient's lives with a new form of treatment
In this article: SGMO, BIIB, GILD, SHPG
Read
E Small Cap Report
Article By: E.B. Capital Markets Thursday, March 20, 2014 1:39 PM EST
The highest scoring names in small cap from 1 year ago (3/20/2013) returned 3,708 bps more than the S&P 500. The best performers have been RAD up 255%, CAMP up 205%, JAZZ up 163%, MDSO up 127%, GBX up 109%, and HOMB up 90%.
In this article: CDI, CGX, CHE, CMO, CWT, EXAM, FSS, GBX, GTS, PGI, RAD, STRI, WWE, AFFY, ALIM, ANAC, BABY, CYBX, DXPE, DXYN, ECOL, FLDM, GERN, HOMB, HTWR, IRWD, IVAC, JAZZ, MDSO, MPWR, NLNK, PENX, PHMD, REDF, RTIX, SABA, SGMO, SILC, SNTA, VASC, AGYS, AMED, ANIK, BJRI, BLDR, CAMP, CENX, CFNL, DIOD, ELNK, FINL, FORM, GLRE, LCAV, SNHY, STFC, TQNT, UEIC, UNTD, WIRE, XRTX, EBIX, KERX
Read
1 to 16 of 17 Posts
1 2